Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.006,06
-0,21%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Benitec Biopharma Limited (BNTC) Benitec Biopharma Limited (BNTC) Notizie

BNTC

Benitec Biopharma (BNTC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BNTC
DataOraFonteTitoloSimboloCompagnia
13/12/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
12/12/202400:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
14/11/202422:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
14/11/202422:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
13/11/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
01/11/202422:04Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
23/10/202415:23Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
15/10/202412:08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BNTCBenitec Biopharma Limited
11/10/202422:53Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
01/10/202422:46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BNTCBenitec Biopharma Limited
26/09/202422:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BNTCBenitec Biopharma Limited
08/07/202416:22Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
29/05/202422:32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BNTCBenitec Biopharma Limited
26/02/202415:06Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:BNTCBenitec Biopharma Limited
17/11/202314:00GlobeNewswire Inc.Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:BNTCBenitec Biopharma Limited
13/11/202314:00GlobeNewswire Inc.Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
21/09/202314:00GlobeNewswire Inc.Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
11/08/202319:00GlobeNewswire Inc.Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
10/08/202322:06Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BNTCBenitec Biopharma Limited
09/08/202304:30GlobeNewswire Inc.Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public OfferingNASDAQ:BNTCBenitec Biopharma Limited
07/08/202314:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BNTCBenitec Biopharma Limited
25/07/202319:00GlobeNewswire Inc.Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023NASDAQ:BNTCBenitec Biopharma Limited
07/07/202322:52Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
26/06/202314:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BNTCBenitec Biopharma Limited
26/06/202314:00GlobeNewswire Inc.Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular DystrophyNASDAQ:BNTCBenitec Biopharma Limited
15/06/202322:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BNTCBenitec Biopharma Limited
15/05/202314:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BNTCBenitec Biopharma Limited
15/05/202314:00GlobeNewswire Inc.Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:BNTCBenitec Biopharma Limited
08/05/202314:05GlobeNewswire Inc.Benitec Biopharma to Present at the OPMD International ConferenceNASDAQ:BNTCBenitec Biopharma Limited
08/05/202314:00GlobeNewswire Inc.Benitec Biopharma to Present at the JMP Securities Life Sciences ConferenceNASDAQ:BNTCBenitec Biopharma Limited
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BNTC

La tua Cronologia

EU
FR001400MGQ7
FCT French Prime Cash 20...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network